TLR2 and tuberculosis: Our findings may also have implications for TB vaccine development, since current strategies involve genetically modifying the BCG vaccine, developing adjuvants to strengthen protective responses, or using other attenuated mycobacterial species as potential vaccines [28], all of which may activate TLR2-mediated pathways.